Severe acute interstitial lung disease induced by crizotinib therapy in a patient with c-Met amplification non-small cell lung cancer

To the editor： Severe acute interstitial lung disease is not uncommon during and after irradiation of the lung, but is very rare during crizotinib treatment. We reported here one case of severe acute interstitial lung disease after one month crizotinib treatment.